Takeda Pharmaceutical Company Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TKPHF research report →
About the company
Takeda Pharmaceutical Company Limited, an established global biopharmaceutical entity founded in 1781 and based in Tokyo, Japan, is comprehensively involved in the entire process of bringing new medicines to market. This includes the research, development, production, commercialization, and external licensing of its pharmaceutical products across a vast international footprint, encompassing Japan, the United States, Europe, Canada, Latin America, Russia, and other parts of Asia. The company concentrates its therapeutic endeavors on key medical areas such as digestive health (gastroenterology), rare disorders, treatments derived from blood plasma, cancer care (oncology), and neurological conditions.
- CEO
- Christophe Weber
- IPO
- 2008
- Employees
- 49,281
- HQ
- Tokyo, JP
Price Chart
- Market Cap
- $50.56B
- P/E
- 43.94
- P/S
- 1.88
- P/B
- 1.08
- EV/EBITDA
- 9.38
- Div Yield
- 3.73%
- Gross Margin
- 58.76%
- Op Margin
- 10.54%
- Net Margin
- 4.26%
- ROE
- 2.61%
- ROIC
- 2.59%
- Revenue
- $4.53T · -1.04%
- Net Income
- $192.97B · 78.79%
- EPS
- $123.03 · 79.97%
- Op Income
- $543.85B
- FCF YoY
- 13.28%
- 52W High
- $39.20
- 52W Low
- $26.33
- 50D MA
- $31.90
- 200D MA
- $31.51
- Beta
- 0.09
- Avg Volume
- 7.46K
Get TickerSpark's AI analysis on TKPHF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our TKPHF coverage
Recent articles, reports, and earnings notes.
No research on TKPHF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate TKPHF report →Similar companies
Peers in the same neighborhood.